{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:07:53Z","timestamp":1772791673539,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,27]],"date-time":"2018-03-27T00:00:00Z","timestamp":1522108800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genet"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12881-018-0565-1","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T22:39:14Z","timestamp":1522795154000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["MiR-146a G\/C rs2910164 variation in South African Indian and Caucasian patients with psoriatic arthritis"],"prefix":"10.1186","volume":"19","author":[{"given":"Ajesh B.","family":"Maharaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pragalathan","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terisha","family":"Ghazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naeem S.","family":"Abdul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shanel","family":"Dhani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taskeen F.","family":"Docrat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prithiksha","family":"Ramkaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul-Peter","family":"Tak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niek","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4649-4133","authenticated-orcid":false,"given":"Anil A.","family":"Chuturgoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,27]]},"reference":[{"key":"565_CR1","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/1346-8138.13806","volume":"44","author":"J Zeng","year":"2017","unstructured":"Zeng J, Luo S, Huang Y, Lu Q. Critical role of environmental factors in the pathogenesis of psoriasis. J Dermatol. 2017;44:863\u201372.","journal-title":"J Dermatol."},{"issue":"14","key":"565_CR2","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1001\/jama.296.14.1735","volume":"296","author":"JM Gelfand","year":"2006","unstructured":"Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA. 2006;296(14):1735\u201341.","journal-title":"JAMA"},{"issue":"3","key":"565_CR3","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.semarthrit.2016.05.012","volume":"46","author":"LC Coates","year":"2016","unstructured":"Coates LC, FitzGerald O, Helliwell PS, Paul C. Psoriasis, psoriatic arthritis, and rheumatoid arthritis: is all inflammation the same? Semin Arthritis Rheum. 2016;46(3):291\u2013304.","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"565_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jaad.2005.03.046","volume":"53","author":"JM Gelfand","year":"2005","unstructured":"Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad T. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005;53(4):573. e571-573. e513","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"565_CR5","first-page":"1354","volume":"35","author":"Y Alamanos","year":"2008","unstructured":"Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol. 2008;35(7):1354\u20138.","journal-title":"J Rheumatol"},{"issue":"2","key":"565_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/00002281-200203000-00004","volume":"14","author":"WJ Taylor","year":"2002","unstructured":"Taylor WJ. Epidemiology of psoriatic arthritis. Curr Opin Rheumatol. 2002;14(2):98\u2013103.","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"565_CR7","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1042\/BST0361224","volume":"36","author":"G Cannell Ian","year":"2008","unstructured":"Cannell Ian G, Kong Yi W, Bushell M. How do microRNAs regulate gene expression? Biochem Soc Trans. 2008;36(6):1224\u201331.","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"565_CR8","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs. Cell. 2004;116(2):281\u201397.","journal-title":"Cell"},{"key":"565_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/cge.12950","volume":"92","author":"X Liu","year":"2017","unstructured":"Liu X, Han Z, Yang C. Associations of microRNA single nucleotide polymorphisms and disease risk and pathophysiology. Clin Genet. 2017;92:235\u201342.","journal-title":"Clin Genet"},{"key":"565_CR10","doi-asserted-by":"publisher","first-page":"584852","DOI":"10.1155\/2014\/584852","volume":"2014","author":"I Omrane","year":"2014","unstructured":"Omrane I, Kourda N, Stambouli N, Privat M, Medimegh I, Arfaoui A, Uhrhammer N, Bougatef K, Baroudi O, Bouzaienne H, et al. MicroRNAs 146a and 147b biomarkers for colorectal Tumor's localization. Biomed Res Int. 2014;2014:584852.","journal-title":"Biomed Res Int"},{"issue":"578","key":"565_CR11","first-page":"1","volume":"5","author":"R Saba","year":"2014","unstructured":"Saba R, Sorensen DL, Booth SA. MicroRNA-146a: a dominant, negative regulator of the innate immune response. Front Immunol. 2014;5(578):1\u201311.","journal-title":"Front Immunol"},{"issue":"1","key":"565_CR12","first-page":"56","volume":"8","author":"B De Felice","year":"2015","unstructured":"De Felice B, Manfellotto F, Palumbo A, Troisi J, Zullo F, Di Carlo C, Sardo ADS, De Stefano N, Ferbo U, Guida M. Genome\u2013wide microRNA expression profiling in placentas from pregnant women exposed to BPA. BMC Med Genet. 2015;8(1):56.","journal-title":"BMC Med Genet"},{"key":"565_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/916202","volume":"2014","author":"Y Shao","year":"2014","unstructured":"Shao Y, Li J, Cai Y, Xie Y, Ma G, Li Y, Chen Y, Liu G, Zhao B, Cui L. The functional polymorphisms of miR-146a are associated with susceptibility to severe sepsis in the Chinese population. Mediat Inflamm. 2014;2014:1\u201310.","journal-title":"Mediat Inflamm"},{"issue":"2","key":"565_CR14","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s12013-013-9704-7","volume":"68","author":"P Ramkaran","year":"2014","unstructured":"Ramkaran P, Khan S, Phulukdaree A, Moodley D, Chuturgoon AA. miR-146a polymorphism influences levels of miR-146a, IRAK-1, and TRAF-6 in young patients with coronary artery disease. Cell Biochem Biophys. 2014;68(2):259\u201366.","journal-title":"Cell Biochem Biophys"},{"key":"565_CR15","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.7754\/Clin.Lab.2016.160124","volume":"62","author":"B Alipoor","year":"2016","unstructured":"Alipoor B, Meshkani R, Ghaedi H, Sharifi Z, Panahi G, Golmohammadi T. Association of miR-146a rs2910164 and miR-149 rs2292832 variants with susceptibility to type 2 diabetes. Clin Lab. 2016;62:1553\u201361.","journal-title":"Clin Lab"},{"issue":"20","key":"565_CR16","doi-asserted-by":"publisher","first-page":"7269","DOI":"10.1073\/pnas.0802682105","volume":"105","author":"K Jazdzewski","year":"2008","unstructured":"Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci. 2008;105(20):7269\u201374.","journal-title":"Proc Natl Acad Sci"},{"issue":"11","key":"565_CR17","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1111\/jcmm.12359","volume":"18","author":"W Zhang","year":"2014","unstructured":"Zhang W, Yi X, Guo S, Shi Q, Wei C, Li X, Gao L, Wang G, Gao T, Wang L. A single-nucleotide polymorphism of miR-146a and psoriasis: an association and functional study. J Cell Mol Med. 2014;18(11):2225\u201334.","journal-title":"J Cell Mol Med"},{"issue":"5","key":"565_CR18","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1365-3083.2010.02381.x","volume":"71","author":"A Chatzikyriakidou","year":"2010","unstructured":"Chatzikyriakidou A, Voulgari P, Georgiou I, Drosos A. The role of microRNA-146a (miR-146a) and its target IL-1R-associated kinase (IRAK1) in psoriatic arthritis susceptibility. Scand J Immunol. 2010;71(5):382\u20135.","journal-title":"Scand J Immunol"},{"issue":"1","key":"565_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3899\/jrheum.141023","volume":"42","author":"AB Maharaj","year":"2015","unstructured":"Maharaj AB, Tak PP. Spondyloarthritis in African blacks. J Rheumatol. 2015;42(1):139.","journal-title":"J Rheumatol"},{"issue":"8","key":"565_CR20","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1002\/art.21972","volume":"54","author":"W Taylor","year":"2006","unstructured":"Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis & Rheumatology. 2006;54(8):2665\u201373.","journal-title":"Arthritis & Rheumatology"},{"key":"565_CR21","unstructured":"Post-hoc Power Calculator: Evaluate statistical power of an existing study. \n                    http:\/\/clincalc.com\/stats\/power.aspx\n                    \n                  . Accessed 20 Nov 2017."},{"issue":"4","key":"565_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1592\/phco.21.5.405.34503","volume":"21","author":"M Levine","year":"2001","unstructured":"Levine M, Ensom MH. Post hoc power analysis: an idea whose time has passed? Pharmacotherapy. 2001;21(4):405\u20139.","journal-title":"Pharmacotherapy"},{"issue":"6","key":"565_CR23","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/jdv.12257","volume":"28","author":"S Beygi","year":"2014","unstructured":"Beygi S, Lajevardi V, Abedini R. C-reactive protein in psoriasis: a review of the literature. J Eur Acad Dermatol Venereol. 2014;28(6):700\u201311.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"565_CR24","first-page":"GC01","volume":"10","author":"A Sudhesan","year":"2016","unstructured":"Sudhesan A, Rajappa M, Chandrashekar L, Ananthanarayanan PH, Thappa DM, Satheesh S, Chandrasekaran A, Devaraju P. Association of C-reactive protein (rs1205) gene polymorphism with susceptibility to psoriasis in south Indian Tamils. J Clin Diagn Res. 2016;10(10):GC01.","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"565_CR25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3892\/mmr.2012.1176","volume":"7","author":"M Hashemi","year":"2013","unstructured":"Hashemi M, Eskandari-Nasab E, Zakeri Z, Atabaki M, Bahari G, Jahantigh M, Taheri M, Ghavami S. Association of pre-miRNA-146a rs2910164 and pre-miRNA-499 rs3746444 polymorphisms and susceptibility to rheumatoid arthritis. Mol Med Rep. 2013;7(1):287\u201391.","journal-title":"Mol Med Rep"},{"issue":"2","key":"565_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1089\/gtmb.2016.0270","volume":"21","author":"HB Hassine","year":"2017","unstructured":"Hassine HB, Boumiza A, Sghiri R, Baccouche K, Boussaid I, Atig A, Shakoor Z, Bouajina E, Zemni R. Micro RNA-146a but not IRAK1 is associated with rheumatoid arthritis in the Tunisian population. Genet Test Mol Biomarkers. 2017;21(2):92\u20136.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"5","key":"565_CR27","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1590\/abd1806-4841.20164655","volume":"91","author":"M Farshchian","year":"2016","unstructured":"Farshchian M, Ansar A, Sobhan M, Hoseinpoor V. C-reactive protein serum level in patients with psoriasis before and after treatment with narrow-band ultraviolet B. An Bras Dermatol. 2016;91(5):580\u20133.","journal-title":"An Bras Dermatol"},{"key":"565_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/145769","volume":"2015","author":"AM Ele-Refaei","year":"2015","unstructured":"Ele-Refaei AM, El-Esawy FM. Effect of narrow-band ultraviolet B phototherapy and methotrexate on MicroRNA (146a) levels in blood of psoriatic patients. Dermatol Res Pract. 2015;2015:1\u20135.","journal-title":"Dermatol Res Pract"},{"issue":"6","key":"565_CR29","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1590\/abd1806-4841.20165080","volume":"91","author":"AV Carvalho","year":"2016","unstructured":"Carvalho AV, Romiti R, Souza CD, Paschoal RS, Milman LD, Meneghello LP. Psoriasis comorbidities: complications and benefits of immunobiological treatment. An Bras Dermatol. 2016;91(6):781\u20139.","journal-title":"An Bras Dermatol"},{"issue":"3","key":"565_CR30","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/jid.2011.365","volume":"132","author":"SM Langan","year":"2012","unstructured":"Langan SM, Seminara NM, Shin DB, Troxel AB, Kimmel SE, Mehta NN, Margolis DJ, Gelfand JM. Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Investig Dermatol. 2012;132(3):556\u201362.","journal-title":"J Investig Dermatol"},{"issue":"1","key":"565_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.intimp.2015.05.030","volume":"29","author":"Y Moriwaki","year":"2015","unstructured":"Moriwaki Y, Takada K, Tsuji S, Kawashima K, Misawa H. Transcriptional regulation of SLURP2, a psoriasis-associated gene, is under control of IL-22 in the skin: a special reference to the nested gene LYNX1. Int Immunopharmacol. 2015;29(1):71\u20135.","journal-title":"Int Immunopharmacol"},{"key":"565_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1741-7015-11-195","volume":"11","author":"SN Slagter","year":"2013","unstructured":"Slagter SN, van Vliet-Ostaptchouk JV, Vonk JM, Boezen HM, Dullaart RP, Kobold AC, Feskens EJ, van Beek AP, van der Klauw MM, Wolffenbuttel BH. Associations between smoking, components of metabolic syndrome and lipoprotein particle size. BMC Med. 2013;11:1\u201315.","journal-title":"BMC Med"}],"container-title":["BMC Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-018-0565-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12881-018-0565-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12881-018-0565-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T20:41:40Z","timestamp":1553632900000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenet.biomedcentral.com\/articles\/10.1186\/s12881-018-0565-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,27]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["565"],"URL":"https:\/\/doi.org\/10.1186\/s12881-018-0565-1","relation":{},"ISSN":["1471-2350"],"issn-type":[{"value":"1471-2350","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,27]]},"assertion":[{"value":"10 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study received ethical approval from the Pharma-Ethics Research Ethics Committee of South Africa (Reference number: 13095660). All participants signed informed consent prior to enrolment.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"48"}}